Khaitan & Co and _Skadden, Arps, Slate, Meagher & Flom_ acted for clinical trial service provider Bioclinica in its aqcuisition of global pharmacovigilance, regulatory affairs and IT services provider Synowledge. Synowledge was advised by Goodwin Procter and Nishith Desai Associates (NDA).

Khaitan partner Rajat Mukherjee, executive director Daksha Baxi, associate partner Kabir Bogra, principal associates Monika Srivastava, Ritu Shaktawat and Sameer Sah, associates Nidhi Killawala, Sanchit Agarwal and Shreya Shree and Skadden Arps partner Robert Pincus, counsel Faiz Ahmad and associate Vincent J Cannizzaro acted for Bioclinica.

NDA partners Mansi Seth and Nishchal Joshipura and Goodwin partner Stuart Rosenthal and associate Oreste Cipolla acted for Synowledge.

Synowledge employs around 500 persons in North America, Europe, India and Japan. The founder of Synowledge, Sankesh Abbhi would serve as senior vice president and head of global safety and regulatory solutions at the merged entity reported Outsourcing Pharma.